Form 4: Phreesia Director Sells Shares Under Pre-Arranged Trading Plan

Phreesia, Inc. Director Lisa Egbuonu-Davis sold 465 shares of common stock for $27.64 per share on July 15, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Summary

• Lisa Egbuonu-Davis, a Director of Phreesia, Inc. (PHR), reported the sale of 465 shares of common stock.
• The transaction occurred on July 15, 2025, at a price of $27.64 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the Reporting Person on September 24, 2024.
• Following this transaction, Lisa Egbuonu-Davis beneficially owns 21,572 shares of Phreesia common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a director selling shares can be seen as a minor negative, the transaction was pre-planned under a Rule 10b5-1 plan, which suggests it's for personal financial management (e.g., diversification, liquidity) rather than a reflection of a negative outlook on the company. The small number of shares sold also limits any significant negative interpretation.

Negatives

• The sale of shares by a director, even under a pre-arranged plan, reduces insider ownership, which can sometimes be perceived as a minor negative signal by investors.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends.

Related Party Transactions

• Lisa Egbuonu-Davis, a Director of Phreesia, Inc., sold 465 shares of the company's common stock. This is a direct transaction between a related party (insider) and the market.

Stakeholder Impact

• Shareholders: The sale of a small number of shares by a director under a pre-arranged plan is unlikely to have a significant direct impact on shareholders, though it slightly reduces insider ownership.

Key Dates

Keywords

Phreesia, PHR, Form 4, Insider Trading, Stock Sale, Director, Rule 10b5-1, Equity Transaction, SEC Filing